Navigation Links
Lilly Announces Senior Leadership Change
Date:1/30/2009

INDIANAPOLIS, Jan. 30 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced that Enrique Conterno, currently senior vice president of health care professional markets for Lilly in the U.S., has been promoted to president, Lilly USA, LLC. Conterno will succeed Deirdre Connelly, who has led Lilly's U.S. operations since 2005. Connelly has resigned from the company to pursue other opportunities.

Conterno joined Lilly as a sales representative in 1992. From 1993 to 1995, he held roles as a financial analyst, marketing associate, and business development manager. In 1996, Conterno became sales and marketing director for Lilly's Peru affiliate, and in 1998 he assumed the same role for Lilly Brazil. In 2000, Conterno was named executive director of marketing for Lilly's intercontinental region (all international markets except for Europe and Japan). In 2003, Conterno became general manager of Lilly Mexico, and in 2006 he was promoted to vice president of Lilly's neuroscience business unit in the U.S. He then assumed his current role in June 2008.

Born in Lima, Peru, Conterno received a master's of business administration degree from Duke University in 1992. He also holds a bachelor's degree in mechanical engineering from Case Western Reserve University that he received in 1989.

"Enrique brings more than 16 years of proven results and strong leadership to one of the company's most important positions," said John Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer. "He understands the complexities of the U.S. marketplace, he has stressed the need to accelerate the transformation that is underway at this company, and he is focused on the needs of the patients we serve. I am pleased that Enrique has accepted this challenge and am confident that he will succeed in this key leadership role. "

Conterno will report to Bryce Carmine, executive vice president of global marketing and sales. He will join the company's operations committee, and will remain a member of the senior management council. Conterno will assume his new role immediately.

Deirdre Connelly, former president of Lilly USA, LLC, has resigned from the company effective immediately to pursue other career interests.

Said Lechleiter, "We regret that Deirdre has decided to leave Lilly. Her passion for the patients we serve will be greatly missed. She has delivered strong results in every role she has held at Lilly. She has displayed a remarkable level of energy and integrity, and she has built a team and a culture that have proven to be successful. We wish her all the best in her future endeavors. Enrique Conterno, I am confident, will build further on the foundation Deirdre and her team have established."

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )

C-LLY


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lilly Reports Fourth-Quarter and Full-Year 2008 Results
2. NFL Quarterback Jay Cutler to Help Families Affected by Diabetes by Joining Lillys Inspired by Diabetes Campaign
3. Law Firm Freedland Russo Spearheads Record-Setting Whistleblower Case Against Pharmaceutical Giant Eli Lilly -- Firm Expands Offices to Include L.A. Entertainment Branch
4. Lilly to Sponsor Martin Luther King Day I AM CHANGE Campaign as Part of Inaugural Gift to President-Elect Obama
5. Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices
6. Whistleblowers Complaints Lead Eli Lilly to Pay $800 Million to Settle Civil Medicaid Fraud Charges, According to Berg & Androphy
7. Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa
8. Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
9. Lilly Files Form 8-K/A Detailing Pro Forma Impact of ImClone Acquisition
10. Lilly Sets Date and Conference Call for Fourth-Quarter and Full-Year 2008 Financial Results Announcement
11. Lilly Announces Dividend Increase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Georgia State University College ... academic programs. , Answering to the increasing demand for curricular specializations, the Certificate ... and environmental and land use law. ,  , “The demand for lawyers with ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For ... their lives in military battle for the country. The nonprofit Hope For Heroes ... more programs that empower independence for disabled military veterans, as well as police, firemen, ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... one that has a significant negative impact on long-term patient survival, reports a ... The results, published online this week in the Journal of Thoracic and Cardiovascular ...
(Date:5/26/2016)... ... 2016 , ... MadgeTech will be showcasing its line of data logging ... at the MadgeTech headquarters. With products sold in more than 100 countries around the ... NASA. , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech data ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James Maisel will ... Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public ... Retina Group of New York , is a Board Certified ophthalmologist who ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... WELLESLEY, Massachusetts , May 26, 2016 ... sequencing (NGS) has matured into an essential life science ... research and development applications. BCC Research reveals in its ... of a second growth phase, one powered by a ... applied fields.      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ...
(Date:5/25/2016)... May 25, 2016 According to ... Type (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic ... User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to ... Medical Animation Market for the forecast period of 2016 ... 301.3 Million by 2021 from USD 117.3 Million in ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, ... QGEN ; Frankfurt Prime Standard: QIA) today announced that the ... Therawis Diagnostics GmbH to develop and commercialize predictive assays in ... PITX2 as a marker to predict effectiveness of anthracycline treatment ... "We are pleased to partner with Therawis, which developed ...
Breaking Medicine Technology: